David Slinkman - 15 May 2023 Form 4 Insider Report for QUAKER CHEMICAL CORP (KWR)

Role
SVP - Chief Technology Officer
Signature
Victoria K. Gehris, Attorney-in-Fact for David Slinkman
Issuer symbol
KWR
Transactions as of
15 May 2023
Net transactions value
-$210,142
Form type
4
Filing time
16 May 2023, 16:30:24 UTC
Previous filing
03 Apr 2023
Next filing
19 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KWR Common Stock Options Exercise $114,021 +736 +16% $154.92 5,418 15 May 2023 Direct
transaction KWR Common Stock Sale $150,294 -736 -14% $204.20 4,682 15 May 2023 Direct
transaction KWR Common Stock Options Exercise $319,874 +2,341 +50% $136.64 7,023 15 May 2023 Direct
transaction KWR Common Stock Sale $478,040 -2,341 -33% $204.20 4,682 15 May 2023 Direct
transaction KWR Common Stock Options Exercise $108,044 +606 +13% $178.29 5,288 15 May 2023 Direct
transaction KWR Common Stock Sale $123,747 -606 -11% $204.20 4,682 15 May 2023 Direct
holding KWR Common Stock 62 15 May 2023 By 401(k) F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KWR Employee Stock Option (right to buy) Options Exercise $0 -736 -100% $0.000000* 0 15 May 2023 Common Stock 736 $154.92 Direct F2
transaction KWR Employee Stock Option (right to buy) Options Exercise $0 -2,341 -100% $0.000000* 0 15 May 2023 Common Stock 2,341 $136.64 Direct F3
transaction KWR Employee Stock Option (right to buy) Options Exercise $0 -606 -33% $0.000000 1,213 15 May 2023 Common Stock 606 $178.29 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Information based on reporting person's Plan Statement as of March 31, 2023.
F2 The options for this grant vested in three annual installments: 737 shares on February 25, 2020; 737 shares on February 25, 2021; and 736 shares on February 25, 2022.
F3 The options for this grant vested in three annual installments: 781 shares on March 30, 2021; 780 shares on March 30, 2022; and 780 shares on March 30, 2023.
F4 The options for this grant vest in three annual installments: 606 shares on March 16, 2023; 606 shares on March 16, 2024; and 607 shares on March 16, 2025.